Coronary heart disease (CHD) is a disease such as angina pectoris caused by lumen stenosis caused by coronary atherosclerosis. It is one of the cardiovascular diseases with high morbidity and mortality. The pathogenesis of the disease is very complex, and there are many inducing factors. Modern studies have shown that intestinal flora is a new target for the prevention and treatment of CHD. Inflammation caused by intestinal flora imbalance and its metabolites such as short-chain fatty acids (SCFAs), bile acids (BAs) and trimethylamine oxide (TMAO) can directly or indirectly affect the development of CHD. In recent years, Chinese medicine intervention on intestinal flora in the prevention and treatment of CHD has been a hot topic. Modern doctors have made many achievements in the use of traditional Chinese medicine to intervene intestinal flora in the prevention and treatment of CHD based on the theory of "heart-to-small intestine", the theory of homology of medicine and food, and the theory of acupuncture and moxibustion. This paper summarizes the research on the intervention of traditional Chinese medicine on intestinal flora in the prevention and treatment of CHD by consulting relevant contributions in Chinese and English in recent years. It is found that monomers or extracts of traditional Chinese medicine, Chinese medicine pairs and traditional Chinese medicine preparations can regulate the occurrence and development of CHD by interfering with intestinal flora, such as regulating the risk factors of CHD, such as blood glucose and blood lipids, or increasing the production of SCFAs to prevent atherosclerosis, reducing the production of TMAO and preventing thrombosis. It is expected that this discussion can provide a new idea for traditional Chinese medicine to interfere with intestinal flora in the prevention and treatment of CHD.

Wang Yiming, Feng Lanshuan, Zhang Jie. The Relationship between Intestinal Microflora and Coronary Heart Disease and the Research Status of Traditional Chinese Medicine Intervention. International Journal of Frontiers in Medicine (2023), Vol. 5, Issue 7: 1-6. https://doi.org/10.25236/IJFM.2023.050701.

[1] Li Guangzhi, Lin Shengxin, Liao Mei, etc. Study on Therapeutic effect of Xuefu Zhuyu decoction on Coronary Heart Disease and changes of Blood Lipid and MCP-1 [J]. Chinese Journal of traditional Chinese Medicine, 2023 and 41 (01): 194-197. 

[2] Zhang Yunbo. Clinical observation of Xuefu Zhuyu decoction combined with β-blocker in the treatment of angina pectoris with heart blood stasis syndrome [J]. Shanxi Medical Journal, 2020, 49 (22): 3117-3119. 

[3] Jin Mengchao, Qian Zhiyuan, Yin Jiayu, et al. The role of intestinal microbiota in cardiovascular disease. [J]. Journal of cellular and molecular medicine, 2019, 23(4). 

[4] Rodrigues Hoffmann A, Proctor LM, Surette MG, et al. The Microbiome: The Trillions of Microorganisms That Maintain Health and Cause Disease in Humans and Companion Animals [J]. Vet Pathol. 2016 Jan; 53(1):10-21. 

[5] Wang Lu, Wang Shiqi, Zhang Qing, et al. The role of the gut microbiota in health and cardiovascular diseases. [J]. Molecular biomedicine, 2022, 3(1). 

[6] Kaisa Hiippala, Hanne Jouhten, Aki Ronkainen, et al. The Potential of Gut Commensals in Reinforcing Intestinal Barrier Function and Alleviating Inflammation [J]. Nutrients, 2018, 10(8). 

[7] Hornef Mathias. Pathogens, Commensal Symbionts, and Pathobionts: Discovery and Functional Effects on the Host. [J]. ILAR journal, 2015, 56(2). 

[8] Cerf-Bensussan N, Gaboriau-Routhiau V. The immune system and the gut microbiota: friends or foes? [J]. Nat Rev Immunol. 2010 Oct;10(10):735-44. 

[9] Jaradat Ziad W, Al Mousa Waseem, Elbetieha Ahmed, Al Nabulsi Anas, Tall Ben D. Cronobacter spp. --opportunistic food-borne pathogens. A review of their virulence and environmental-adaptive traits. [J]. Journal of medical microbiology, 2014, 63(Pt 8). 

[10] Wujun Chen, Shun Zhang, Jianfeng Wu, et al. Butyrate-producing bacteria and the gut-heart axis in atherosclerosis [J]. Clinica Chimica Acta, 2020, 507(prepublish). 

[11] Yuan Jian, Yin Limei, Chen Kai, et al. Based on the appearance of heart and small intestine, to explore the theory of stasis toxin in the prevention and treatment of coronary heart disease [J]. Shi Zhenguo Medicine, 2022 Journal 33 (04): 928-930. 

[12] Bajinka Ousman, Darboe Alansana, Tan Yurong, et al. Gut microbiota and the human gut physiological changes[J]. Annals of Microbiology, 2020, 70(1). 

[13] Sommer F, Anderson JM, Bharti R, et al. The resilience of the intestinal microbiota influences health and disease [J]. Nat Rev Microbiol. 2017; 15(10):630–638. 

[14] Yuji Nagatomo, W. H. Wilson Tang. Intersections Between Microbiome and Heart Failure: Revisiting the Gut Hypothesis [J]. Journal of Cardiac Failure, 2015, 21(12). 

[15] Michael A. Fischbach, Justin L. Sonnenburg. Eating For Two: How Metabolism Establishes Interspecies Interactions in the Gut [J]. Cell Host & Microbe, 2011, 10(4). 

[16] Tang W H Wilson, Kitai Takeshi, Hazen Stanley L. Gut Microbiota in Cardiovascular Health and Disease. [J]. Circulation research, 2017, 120(7). 

[17] J. Mark Brown, Stanley L. Hazen. The Gut Microbial Endocrine Organ: Bacterially Derived Signals Driving Cardiometabolic Diseases [J]. Annual Review of Medicine, 2015, 66(1)

[18] Hideo Ohira, Wao Tsutsui, Yoshio Fujioka. Are Short Chain Fatty Acids in Gut Microbiota Defensive Players for Inflammation and Atherosclerosis? [J]. Journal of Atherosclerosis and Thrombosis, 2017, 24(7). 

[19] Kiriyama Yoshimitsu, Nochi Hiromi. Physiological Role of Bile Acids Modified by the Gut Microbiome [J]. Microorganisms, 2021, 10(1). 

[20] Simultaneous inhibition of FXR and TGR5 exacerbates atherosclerotic formation [J]. Journal of Lipid Research, 2018, 59(9). 

[21] Liang X, Zhang Z, Lv Y, et al. Krill oil combined with bifidobacterium animalis subsp Lactis F1–7 alleviates the atherosclerosis of apoe(-/-) mice[J]. Foods. 2021; 10(10):2374. 

[22] Pols Thijs W H. TGR5 in inflammation and cardiovascular disease. [J]. Biochemical Society transactions, 2014, 42(2). 

[23] Katsimichas T, Antonopoulos AS, Katsimichas A, et al. The intestinal microbiota and cardiovascular disease [J]. Cardiovasc Res. 2019 Aug 1; 115(10):1471-1486.

[24] Xie G, Yan A, Lin P, et al. Trimethylamine N-oxide-a marker for atherosclerotic vascular disease [J]. Rev Cardiovasc Med. 2021 Sep 24; 22(3):787-797.

[25] Singh S, Singh T G. Role of Nuclear Factor Kappa B (NF-kappaB) Signalling in Neurodegenerative Diseases: An Mechanistic Approach [J]. Curr Neuropharmacol, 2020, 18(10): 918-935. 

[26] Ma GuoHua, Pan Bing, Chen Yue, et al. Trimethylamine N-oxide in atherogenesis: impairing endothelial self-repair capacity and enhancing monocyte adhesion. [J]. Bioscience reports, 2017, 37(2). 

[27] Zhang Xiaomei, Liu Tianhao, Wei Na, et al. Based on the intestinal microenvironment, this paper discusses the connotation and denotation of "mind dominates the mind" [J]. Journal of traditional Chinese Medicine, 2017. 58 (19): 1629-1632. 

[28] Novel Concept of a Heart-Gut Axis in the Pathophysiology of Heart Failure[J]. Korean Circulation Journal, 2017, 47(5). 

[29] He Dongmei, Lai Changjiangsheng, Yan Zhuyun, etc. Research and prospect of microecology of traditional Chinese medicine [J]. Miscellaneous Records of traditional Chinese Medicine, 2018 Magna 43 (17): 3417-3430. 

[30] Yang Zhihua, Deng Liuyi, Li Dongmei, et al. Study on the regulatory effect of traditional Chinese medicine compound on intestinal microecology [J]. Western Chinese Medicine, 2020 and 33 (09): 166-168. 

[31] Zou Taiji, Liang Zhuanghua, Shen Lingjie, et al. Research status of intervention of traditional Chinese medicine on intestinal flora in the prevention and treatment of diabetes [J]. International Journal of Geriatrics, 2022 743 (03): 357-360. 

[32] Watanabe Mitsuhiro, Houten Sander M, Mataki Chikage, et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. [J]. Nature, 2006, 439(7075). 

[33] Matsuoka Katsuyoshi, Kanai Takanori. The gut microbiota and inflammatory bowel disease. [J]. Seminars in immunopathology, 2015, 37(1). 

[34] Wang Leilei, Tao Mengxuan. Difference of intestinal flora between pregnant women with gestational diabetes mellitus and healthy pregnant women [J]. Journal of Shanghai Jiaotong University (Medical Edition), 2019. 39 (11): 1300-1305. 

[35] Chang Keun Kim, Mihyun Kim, Sang Deog Oh, et al. Effects of Atractylodes macrocephala Koidzumi rhizome on 3T3-L1 adipogenesis and an animal model of obesity[J]. Journal of Ethnopharmacology, 2011, 137(1). 

[36] Joo Seong Soo, Won Tae Joon, Nam Sang Yoon, et al. Therapeutic advantages of medicinal herbs fermented with Lactobacillus plantarum, in topical application and its activities on atopic dermatitis. [J]. Phytotherapy research: PTR, 2009, 23(7). 

[37] Wang Jing-Hua, Bose Shambhunath, Kim Hyung-Gu, et al. Fermented Rhizoma Atractylodis Macrocephalae alleviates high fat diet-induced obesity in association with regulation of intestinal permeability and microbiota in rats. [J]. Scientific reports, 2015, 5(1). 

[38] Shapiro H, Kolodziejczyk A A, Halstuch D, et al. Glucose metabolism of bile acids in health and disease [J]. The Journal of experimental medicine, 2018, 215(2): 383-396. 

[39] Mu Guohua, Zhao Zongjiang, Zhou Yanya, et al. Effects of Coptis cinnamon on intestinal flora, inflammatory factors and short-chain fatty acids in db/db mice [J]. Journal of Beijing University of traditional Chinese Medicine, 2021 Journal 44 (02): 134-142. 

[40] Gao Ruolin, Zhang Pengyi. Effects of traditional Chinese medicine Coptis chinensis and cinnamon combined with aerobic and resistance exercise on intestinal flora and short-chain fatty acids in db/db mice [C] / / Chinese Sports Science Society. Abstract compilation of the 12th National Sports Science Congress-Wall newspaper Exchange (Sports Physiology and Biochemistry Branch). Abstract compilation of papers of the 12th National Sports Science Congress-Wall newspaper Exchange (Sports Physiology and Biochemistry Branch), 2022VOF 287-289. 

[41] Feng Q, Liu W, Baker S S, et al. Multi-targeting therapeutic mechanisms of the Chinese herbal medicine QHD in the treatment of non-alcoholic fatty liver disease[J]. Oncotarget, 2017, 8(17): 27820. 

[42] Li Yubo, Hao Gaimei, Jia Haihua, et al. To explore the effect of Yueju Pill on blood fat of ApoE mice from the diversity of intestinal flora [J]. Chinese Journal of basic Medicine of traditional Chinese Medicine, 2017 Journal 23 (11): 1559-1563. 

[43] Dong Mingxia, Yang Sici, Tu Huan. Clinical effect of Huangqin decoction combined with metformin in the treatment of type 2 diabetes and its effect on the composition of intestinal flora [J]. Clinical Medical Research and practice, 2022 Journal 7 (32): 128-130.